These are short-lived mono- or bispecific molecules, for example against the growth factor EGFR (“epidermal growth factor receptor”), which make the connection between the cytotoxic T-cells and the tumor cells and thus the T lymphocytes to the cancer cells. This evidence concerns the gene EGFR and cancer.